We further investigated the expression patterns of peIF2α, eIF2α, eIF3c, eIF3h, eIF4e, eIF4g, eIF5 and eIF6 in endometrial cancer compared to non-neoplastic patient samples using immunoblot analysis. This evidence concerns the gene EIF4G1 and endometrial cancer.